Trade IRD anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Opus Genetics, Inc. (IRD) is trading at US$3.68, down 4.55% today as of Aug 28, 13:03 EDT. The company has a market capitalisation of US$336.94M. Over the past 52 weeks, IRD has traded between US$1.17 and US$5.81. On Syfe you can trade IRD with $0 commission and add it to your watchlist.
| Previous close | US$3.85 |
|---|---|
| Market cap | US$336.94M |
| 52-week range | US$1.17 – US$5.81 |
| Volume | 538.41K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Opus Genetics, Inc.
Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.
Year: 2020
TD Cowen Initiates Opus Genetics at Buy
Jul 29, 11:45 AM · MT Newswires
Opus Genetics Unlocks Key Milestone With US FDA Alignment on OPGx-LCA5 Phase 3, Wedbush Says
Jul 6, 6:59 PM · MT Newswires
Sector Update: Healthcare Stocks Mixed Premarket Monday
Jul 6, 1:18 PM · MT Newswires
Opus Genetics, Inc. (IRD) stock is trading at US$3.68, -4.55% from the previous close of US$3.85.
The market cap for Opus Genetics, Inc. (IRD) stock is approximately US$336.94M.
The 52-week high for Opus Genetics, Inc. (IRD) stock is US$5.81.
The 52-week low for Opus Genetics, Inc. (IRD) stock is US$1.17.
Opus Genetics, Inc. (IRD) does not currently pay a dividend.
Stay on top of IRD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
